AFT to announce full year results on May 21 2026v

May 8 2026


AFT Pharmaceuticals to announce full year results on Thursday May 21 2026


AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release
its full year FY2026, ended March 31 2026, results on Thursday May 21 2026. The release
will be issued at around 09:00 am (NZT) on the NZX and ASX.

Following the release, management will present via webinar at 10:30 am (NZT).
Presentation material will be available on the company’s website AFT, the NZX website
NZX and the ASX website ASX.

To participate in the upcoming earnings webinar, please pre-register with the link
provided below. Webinar details will be provided upon completion of your
registration.

Registration Link: AFT results presentation FY2026


For and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.

For more information:


Investors Media
Malcolm Tubby Richard Inder
CFO, AFT Pharmaceuticals Ltd The Project
Phone: +64 9 488 0232 Phone: 021 645 643
Email: malcolm.tubby@aftpharm.com Email: richard@theproject.co.nz



AFT is a growing New Zealand based multinational pharmaceutical company that develops,
markets, and distributes a broad portfolio of pharmaceutical products across a wide range of
therapeutic categories which are distributed across all major pharmaceutical distribution
channels: over the counter (OTC), prescription and hospital. Our product portfolio comprises
both proprietary and in-licensed products, and includes patented, branded, and generic
drugs
1
. Our business model is to develop and in-license products for in our markets of Australia,
New Zealand, Singapore, Malaysia, Hong Kong, USA, Canada, EU ex Ireland and UK, and to
out-license our products to local licensees and distributors to over 125 countries around the
world.
For more information about the company, visit our website www.aftpharm.com.